Upregulated Expression of Calcyclin-Binding Protein/Siah-1 Interacting Protein in Malignant Melanoma

670 Ann Dermatol Received August 30, 2013, Revised October 28, 2013, Accepted for publication November 1, 2013 Corresponding author: Masutaka Furue, Department of Dermatology, Kyushu University, Maidashi 3-1-1, Higashiku, Fukuoka 812-8582, Japan. Tel: 81-92-642-5581, Fax: 81-92-642-5600, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. any histopathological evidence of thrombosis, and thus the diagnosis of injection-site reaction of 5-azacitidine was made based on a combination of clinical and histopathological findings. Most injection-site erythema/reactions are resolved by simple continuing treatment, and less than 12% of cases require corticosteroids and/or antihistamine. A correct injection technique, such as syringe aspiration, and injection-site rotation, can help prevent injection-site reaction. REFERENCES